![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 42.00 | ACUITE B+ | Downgraded | Issuer not co-operating* | - |
Bank Loan Ratings | 20.00 | - | ACUITE A4 | Downgraded | Issuer not co-operating* |
Total Outstanding | 62.00 | - | - |
Total Withdrawn | 0.00 | - | - |
* The issuer did not co-operate; based on best available information. |
Rating Rationale |
Acuité has downgraded the long-term rating to ‘ACUITE B+’ (read as ACUITE B plus) from 'ACUITE BB-' (read as ACUITE double B minus) and the short term rating to 'ACUITE A4' (read as ACUITE A four) from ‘ACUITE A4+’ (read as ACUITE A four plus) on the Rs. 62.00 crore bank facilities of Vivek Pharmachem India Limited (VPIL) on account of information risk. The rating continues to be flagged as “Issuer Not-Cooperating” and is based on the best available information. |
About the Company |
Vivek Pharmachem India Limited (VPIL) was established in 1975 as a partnership firm under the name ‘Vivek Pharmaceuticals’. Later, the company was converted to Private Limited in 1990 and in 1993, reconstituted to closely held public limited company. VPIL is a Jaipur based company promoted by Mr. Kuldeep Gupta and family. It is engaged in manufacturing of pharmaceutical formulations such as capsules and tablets, liquid orals and ointments. The company sells its products in India. It is ISO 9001:2008 certified company. VPIL is also engaged in power generation. The company has 9 windmills and 1 solar plant having total installed capacity of 14.25 Mega Watt (MW). |
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower: |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. |
Limitation regarding information availability |
Rating Sensitivity |
"No information provided by the issuer / available for Acuite to comment upon." |
Liquidity Position |
"No information provided by the issuer / available for Acuite to comment upon." |
Outlook |
Not Applicable |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 24 (Actual) | FY 23 (Actual) |
Operating Income | Rs. Cr. | 241.76 | 238.25 |
PAT | Rs. Cr. | 13.01 | 10.61 |
PAT Margin | (%) | 5.38 | 4.45 |
Total Debt/Tangible Net Worth | Times | 0.30 | 0.47 |
PBDIT/Interest | Times | 6.30 | 6.62 |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Manufacturing Entities: https://www.acuite.in/view-rating-criteria-59.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on complexity levels of the rated instrument |
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
* The issuer did not co-operate; based on best available information. |
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |